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BACKGROUND: Asthma and rhinitis often coexist, which potentially increases the disease severity and can
negatively impact a patients’ quality of life. However, there are few reports based on data obtained from the
International Study of Asthma and Allergies in Childhood examining asthma severity in combination with rhinitis-
related symptoms.
OBJECTIVE: To demonstrate whether current rhinitis and current rhinoconjunctivitis are associated with the
development of asthma or its increasing severity in Brazilian adolescents.
METHODS: The prevalence of current asthma was correlated with the prevalence of current rhinitis and current
rhinoconjunctivitis in adolescents (13 to 14 year olds) from 16 Brazilian centers (based on Spearman’s rank
correlation index). The influence of current rhinitis and current rhinoconjunctivitis on asthma presentation was also
evaluated using the chi-squared test and was expressed as odds ratios with 95% confidence intervals (95%CI).
RESULTS: A significant positive correlation was observed between the prevalence of current asthma and current
rhinitis (rs=0.82; 95%CI: 0.60–0.93, p,0.0001) and between the prevalence of current asthma and current
rhinoconjunctivitis (rs=0.75; 95%CI: 0.47–0.89, p,0.0001). Current rhinitis was associated with a significantly
increased risk of current asthma and of more severe asthma. Similar results were observed for current
rhinoconjunctivitis.
CONCLUSION: In this epidemiologic study of Brazilian adolescents, the presence of current rhinitis and current
rhinoconjunctivitis was associated with a high risk of developing asthma and increased asthma severity. The mutual
evaluation of rhinitis and asthma is necessary to establish an adequate treatment plan.
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INTRODUCTION
In the last decade, allergic rhinitis (AR) has become
prominent among allergic diseases due to its prevalence,
negative impact on quality of life, and associated comorbid-
ities.
1,2 Several epidemiological, etiological, anatomical, and
therapeutic similarities between asthma and rhinitis have
been reported.
1-3 It has been hypothesized that both asthma
and AR are manifestations of a single inflammatory process
present throughout the airway and that they represent a
continuum of disease.
3-5 Brown et al. examined bronchial
biopsies from adults with AR and observed an intermediate
state of airway inflammation between that seen in healthy
individuals and subjects with clinical asthma.
6
The prevalence of rhinitis and related symptoms found
by the International Study of Asthma and Allergies in
Childhood (ISAAC) in Phases One (Ph1) and Three (Ph3)
was quite high and variable around the world, with a
sustained high trend.
7,8 Asthma and rhinitis often coexist,
which potentially increases the disease severity and
negatively impacts the quality of life.
9
AR is considered a common condition with a high
morbidity, and it is associated with a reduced quality of life
due to its coexistence with other diseases, such as chronic
sinusitis and asthma.
2,3 AR often precedes the onset of
clinical asthma and has been identified as a risk factor for the
development of asthma in children
10-14 and adults.
13,15-17
Severalstudieshavereported aprevalenceofARinasthma
patients of 80 to 90%.
1-3,10-12 The concomitance of AR and
asthma has been associated with an increase in the healthcare
costs associated with asthma
14,18-22 and an impairment in the
quality of life.
9,19,23 A retrospective study of asthmatic
patients, aged 16 to 55 years, showed that patients with
asthma alone had significantly fewer asthma-related visits to
general practitioners, lower asthma-related drug costs, and
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1573fewer hospitalizations due to asthma than patients with
rhinitis associated with asthma.
24,25 Similar results have been
observed in asthmatic children.
26
In a previous study of 6,520 children and adolescents
enrolled in ISAAC Ph1, we evaluated the effects of rhinitis
alone and rhinitis associated with atopic eczema on asthma
severity in patients identified as asthmatics (23.2%). A
higher prevalence of asthma and severe asthma was
observed in children with rhinitis and/or atopic eczema.
27
To date, few studies using the data from the ISAAC have
examined asthma severity in combination with rhinitis-
related symptoms. Thus, the aim of this study was to
determine whether current rhinitis or current rhinoconjunc-
tivitis are risk factors for the development of asthma or
increased asthma severity in Brazilian adolescents.
28
METHODS
The data presented in this epidemiological study were
previously published and came from 16 centers in 14
Brazilian cities.
28,29 Adolescents (ADs, 13 to 14 years old)
were selected following the ISAAC Ph3 protocol.
30 The cities,
states, and regions/areas in which the study took place were
Manaus (Amazonas, Northern [N]); Caruaru (Pernambuco
[PE], Northeastern [NE]); Aracaju (Sergipe, NE); Feira de
Santana (Bahia [BA], NE); Salvador (BA, NE); Vito ´ria da
Conquista (BA, NE); Brası ´lia (Distrito Federal, Middle-
Western); Nova Iguac ¸u (Rio de Janeiro, Southeastern [SE]);
Sa ˜o Paulo (West and South, Sa ˜o Paulo [SP], SE); Santo Andre ´
(SP, SE); Curitiba (Parana ´, Southern [S]); Itajaı ´ (Santa
Catarina, S); Porto Alegre (Rio Grande do Sul [RS], S) and
Santa Maria (RS, S). The data from all centers were approved
by the ISAAC International Data Center and were considered
ISAAC’s official centers (Table 1).
ISAAC’s written questionnaire (WQ), previously trans-
lated and validated for the Brazilian culture,
31-33 was
completed by 46,770 ADs. The participants were selected
from adolescents who attended public and private schools
located in the participating cities. Only the asthma and
rhinitis core questionnaires were considered in this study.
Information regarding the number of schools and students
in each area was obtained from the appropriate Municipal
Education Secretary’s official records. The data obtained
were transcribed to a database (Epi-Info) supplied by
ISAAC’s coordinators. The frequency of affirmative answers
to specific questions was analyzed.
ADs were identified as having current asthma if they
answered ‘‘yes’’ to the question ‘‘Have you had a wheezing
episode in the last 12 months?’’; as having current rhinitis if
they answered ‘‘yes’’ to the question ‘‘Have you had nasal
problems (sneezing; runny or blocked nose) in the last 12
months without a cold?’’; and as having current rhinocon-
junctivitis if they answered ‘‘yes’’ to the question ‘‘Have you
had nasal problems (sneezing; runny or blocked nose) with
itchy and watery eyes in the last 12 months?’’.
29 ADs were
identified as having severe asthma if they answered ‘‘yes’’
to the question ‘‘Have you had wheezing severe enough to
limit speech in the last 12 months?’’ or at least two of the
following questions: ‘‘Have you had more than 12 wheezing
episodes in the last 12 months?’’, ‘‘Have you had wheezing
with exercise?’’, and ‘‘Have you had nocturnal coughing
without a cold?’’ (atypical form of asthma). Asthma
diagnosed by a physician was considered a medical
diagnosis.
30
To analyze the correlation between the prevalence of
current rhinitis and current rhinoconjunctivitis with current
asthma, Spearman’s rank correlation coefficient was used.
The influence of current rhinitis and current rhinoconjunc-
tivitis on asthma presentation was analyzed using the chi-
square test and is expressed as the odds ratio (OR) with 95%
confidence intervals (95%CI). The study was approved by
all local ethics committees. In all tests, the level of rejection
of the null hypothesis was 5%.
RESULTS
The prevalence of current asthma, current rhinitis, and
current rhinoconjunctivitis was lower in Nova Iguac ¸u and
higher in Salvador and Vito ´ria da Conquista (Table 1). A
significant positive correlation was observed between the
Table 1 - Prevalence of current asthma, current rhinitis, and current rhinoconjunctivitis in Brazilian adolescents from
ISAAC Phase Three centers, based on responses to the ISAAC written questionnaire (determined with Spearman’s
correlation coefficient).
Center n
Current
asthma (%)
Current
rhinitis (%)
Current
rhinoconjunctivitis (%)
Manaus 3,009 18.1 23.0 12.8
Caruaru 3,026 17.9 25.5 15.4
Aracaju 3,041 18.7 25.6 17.4
Feira de Santana 1,732 21.5 33.0 17.2
Salvador 3,020 24.6 44.2 24.4
Vito ´ria da Conquista 1,679 30.5 39.8 24.4
Brası ´lia 3,009 19.7 29.3 15.4
Nova Iguac ¸u 3,185 11.8 17.4 8.9
Sa ˜o Paulo West 3,181 21.9 30.1 19.8
Sa ˜o Paulo South 3,161 18.7 27.4 12.2
Santo Andre ´ 3,232 23.2 28.4 13.8
Curitiba 3,628 18.9 39.2 17.2
Itajaı ´ 2,737 12.3 22.1 12.9
Porto Alegre 3,007 18.2 32.1 15.9
Santa Maria – rural 3,057 15.3 20.6 9.6
Santa Maria – urban 3,066 16.7 24.3 11.4
Spearman’s correlation coefficient:
Current asthma VS. current rhinitis: rs=0.82 (95%CI: 0.60–0.93), p,0.0001.
Current asthma vs. current rhinoconjunctivitis: rs=0.75 (95%CI: 0.47–0.89), p,0.0001.
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1574prevalence of current asthma and current rhinitis and
between the prevalence of current asthma and current
rhinoconjunctivitis (Table 1).
Current rhinitis was associated with a significantly
increased risk (odds ratio [OR]) of current asthma in all
participating centers, with OR ranging from 2.19 (Curitiba)
to 4.36 (Nova Iguac ¸u) (Table 2). Reports of current rhinitis
were also associated with a significant risk of having 12 or
more episodes of acute asthma in nine of 16 centers, with
OR ranging from 0.68 (Salvador) to 8.03 (Sa ˜o Paulo West)
(Table 2). Sleep disturbance was significantly associated
with current rhinitis in 13 of 16 centers, with OR ranging
from 0.92 (Itajaı ´) to 4.45 (Nova Iguac ¸u) (Table 2). Similar
results were found for the risk of speech difficulty due to an
acute asthma attack, which was observed in nine of 16
centers and ranged from 0.72 (Itajaı ´) to 5.18 (Nova Iguac ¸u)
(Table 2). The risk of wheezing with exercise in the last year
was significantly associated with current rhinitis in all
evaluated centers and ranged from 2.38 (Aracaju) to 3.25
(Salvador) (Table 2). The risk of nocturnal cough in the last
year was significantly associated with current rhinitis in all
centers and ranged from 2.99 (Curitiba) to 4.50 (Nova
Iguac ¸u) (Table 2). The risk of physician-diagnosed asthma
was significantly associated with current rhinitis in all
centers and ranged from 1.82 (Manaus) to 3.44 (Vito ´ria da
Conquista) (Table 2).
Current rhinoconjunctivitis was associated with a sig-
nificantly increased risk of current asthma in all participat-
ing centers that ranged from 2.73 (Curitiba) to 6.04 (Nova
Iguac ¸u) (Table 3). It was also associated with a significant
risk of having 12 or more episodes of acute asthma in 10 of
16 participating centers that ranged from 1.31 (Porto Alegre)
to 8.85 (Sa ˜o Paulo West) (Table 3). Sleep disturbance was
significantly associated with current rhinoconjunctivitis in
13 of 16 participating centers, with OR ranging from 1.27
(Itajaı ´) to 5.41 (Nova Iguac ¸u) (Table 3). A similar result was
observed in 13 of 16 centers for speech difficulty due to an
acute asthma attack, with OR ranging from 1.23 (Itajaı ´)t o
7.18 (Nova Iguac ¸u) (Table 3). Wheezing caused by exercise
in the last year was also significantly associated with current
rhinoconjunctivitis in all participating centers, with OR
ranging from 2.77 (Vito ´ria da Conquista) to 4.38 (Itajaı ´)
(Table 3). Nocturnal coughing in the last year was
significantly associated with current rhinoconjunctivitis in
all centers, with OR ranging from 2.79 (Curitiba) to 5.45
(Nova Iguac ¸u) (Table 3). Physician-diagnosed asthma was
significantly associated with current rhinoconjunctivitis in
all centers, with OR ranging from 2.02 (Manaus) to 4.20
(Nova Iguac ¸u) (Table 3).
DISCUSSION
In this multicenter study, we evaluated the majority of the
Brazilian ADs (46,770 or 80.4%) enrolled in ISAAC Ph3,
representing the different regions of Brazil. The mean index
of return of the completed WQ was high (approximately
93%).
30 Our study has some limitations arising from its
ecological nature. Ecological studies are inherently limited
because their analyses are based on a general population
rather than individuals. No individual information is avail-
able regarding confounding factors that might explain the
associations between the studied variable and the outcome.
Therefore, such potential confounding factors can be neither
examined nor controlled for in the analysis. Nevertheless,
such studies can provide useful information about the
potential impact of a disease or drug on a population.
Another point to consider is the validity of self-reported
information (such as the responses to the ISAAC WQ) in
studies using questionnaires; the possibility of inaccuracy
and bias must be considered.
31 However, the ISAAC has
strengths that improve its reliability; these strengths include
its sample size, comprehensiveness, and high response rates;
its inclusion of hitherto unstudied populations; and its use of
an identical, standardized, simple and validated question-
naire based on asthma and rhinitis symptoms.
31
The prevalence of current asthma is assumed to be high in
patients with current AR.
1-3 In this study, we observed a
mean prevalence of current asthma in AD with current
rhinitis of 33.0% and a mean prevalence of current asthma in
AD with current rhinoconjunctivitis of 40.9%. Differences in
Table 2 - Odds ratio (OR) and 95% confidence interval (95% CI) for wheezing-related symptoms in Brazilian adolescents
with current rhinitis from ISAAC Phase Three centers.
Center
Wheezing last
year
OR (95%CI)
.12 wheezing
episodes last year
OR (95%CI)
Sleep disturb.
last year
OR (95%CI)
Speech problems
last year
OR (95%CI)
Asthma ever
OR (95%CI)
Wheezing with
exercise last year
OR (95%CI)
Nocturnal
coughing
last year
OR (95%CI)
Manaus 4.18 (3.43–5.09)* 2.41 (1.02–5.69)* 1.58 (1.12–2.21)* 2.37 (1.57–3.55)* 1.82 (1.49–2.22)* 2.92 (2.40–3.54)* 3.56 (2.98–4.26)*
Caruaru 3.30 (2.72–4.01)* 1.06 (0.46–2.44) 1.44 (1.03–2.02)* 1.37 (0.89–2.11) 2.45 (2.03–2.97)* 3.12 (2.56–3.80)* 3.05 (2.57–3.61)*
Aracaju 3.03 (2.50–3.70)* 1.61 (0.59–4.39) 0.99 (0.71–1.37) 0.83 (0.56–1.23) 2.56 (2.08–3.14)* 2.38 (1.93–2.83)* 3.07 (2.60–3.64)*
Feira Santana 3.67 (2.90–4.66)* 6.93 (1.58–30.5)* 1,81 (1.19–2.74)* 1.35 (0.81–2.24) 2.08 (1.53–2.82)* 2.94 (2.40–3.65)* 3.46 (2.80–4.28)*
Salvador 3.80 (3.18–4.53)* 0.68 (0.33–1.44) 1.71 (1.23–2.37)* 1.57 (1.03–2.40)* 2.47 (2.00–3.06)* 3.25 (2.78–3.80)* 3.24 (2.77–3.80)*
Vito ´ria Conquista 3.47 (2.80–4.30)* 2.90 (0.82–10.32) 1.71 (1.19–2.45)* 1.75 (1.11–2.75)* 3.44 (2.55–4.63)* 3.16 (2.57–3.88)* 3.13 (2.55–3.85)*
Brası ´lia 3.67 (3.05–4.43)* 3.96 (1.12–14.1)* 1.85 (1.33–2.57)* 1.59 (1.01–2.52) 2.42 (1.97–2.97)* 2.77 (2.31–3.33)* 4.25 (3.60–5.02)*
Nova Iguac ¸u 4.36 (3.44–5.52)* 2.35 (0.80–6.90) 4.45 (3.31–5.99)* 5.18 (3.46–7.75)* 2.97 (2.22–3.98)* 3.00 (2.40–3.70)* 4.50 (3.70–5.49)*
Sa ˜o Paulo West 3.75 (3.14–4.46)* 8.03 (2.95– 21.8)* 3.36 (2.75– 4.12)* 4.27 (3.11–5.84)* 2.77 (2.16–3.54)* 3.18 (2.65–3.81)* 3.49 (2.98–4.09)*
Sa ˜o Paulo South 2.91 (2.42–3.51)* 1.69 (0.71–4.02)* 1.56 (1.12–2.18)* 1.70 (1.02–2.85) 2.50 (1.97–3.14)* 2.40 (1.98–2.90)* 3.37 (2.87–3.97)*
Santo Andre ´ 3.32 (2.80–3.94)* 2.62 (1.08–6.40)* 1.61 (1.21–2.16)* 1.59 (1.03–2.45)* 2.28 (1.78–2.91)* 2.53 (2.10–3.05)* 3.30 (2.81–3.87)*
Curitiba 2.19 (1.85–2.59)* 1.68 (0.71–3.99) 1.93 (1.41–2.66)* 2.24 (1.45–3.47)* 2.40 (1.91–3.02)* 2.52 (2.13–2.98)* 2.99 (2.59–3.44)*
Itajaı ´ 3.94 (3.11–4.99)* 1.83 (0.92–3.64) 0.92 (0.60–1.42) 0.72 (0.39–1.35) 3.25 (2.54–4.17)* 3.16 (2.56–3.90)* 3.86 (3.20–4.67)*
Porto Alegre 3.65 (3.02–4.43)* 1.70 (1.04–2.76)* 1.93 (1.37–2.73)* 1.19 (0.77–1.85) 2.40 (2.00–2.87)* 2.88 (2.41–3.44)* 3.31 (2.82–3.89)*
Santa Maria 3.74 (3.03–4.62)* 2.76 (1.30–5.86)* 1.15 (0.79–1.66) 2.20 (1.35–3.59)* 2.61 (2.12–3.22)* 2.78 (2.29–3.37)* 3.83 (3.22–4.55)*
Santa Maria - rural 3.59 (2.94–4.38)* 2.07 (1.16–3.71)* 1.82 (1.28–2.58)* 1.82 (1.12–3.00)* 2.92 (2.30–3.71)* 2.72 (2.23–3.33)* 3.95 (3.29–4.74)*
l* p ,0.05.
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1575the definition of current asthma, current rhinitis or current
rhinoconjunctivitis could explain the differences between
study findings.
In this study, we used definitions used by ISAAC
coordinators and in studies worldwide.
8,9,30,35 The differ-
ences in sensitivity and specificity for diagnosing asthma and
rhinitis via a written questionnaire could also have affected
the results. Despite these differences, as previously reported,
this study found a significant correlation between the
prevalence of current asthma and current rhinitis (rs=0.82;
95%CI: 0.60–0.93) and current asthma and current rhinocon-
junctivitis (rs=0.75; 95%CI: 0.47–0.89), demonstrating that
these diseases are correlated in the studied population.
The association between an asthma diagnosis and current
rhinitis or current rhinoconjunctivitis ranged from 1.82 to
3.44 and from 2.02 to 4.20, respectively, which reinforces the
association between asthma and AR.
Rhinitis in asthmatic patients is a risk factor for severe
asthma and poorly controlled asthma. In a recent prospec-
tive study, severely asthmatic patients who were followed
for one year had a 12.6 times greater risk of having
uncontrolled asthma, a 3.8 times greater risk of having
more visits to the emergency room, a 2.9 times lower risk of
a 10% improvement in airway obstruction, and a 2.9 times
lower risk of a 50% reduction in the emergency room visits
if they had moderate/severe allergic rhinitis.
25
In a previous study, we identified rhinitis as a risk factor
for severe asthma in children and adolescents enrolled in
ISAAC Ph1.
27 The prevalence of severe asthma was 1.6 times
higher in children with asthma and rhinitis living in the
southern area of the city of Sa ˜o Paulo;this prevalenceislower
than the prevalence in the same area in the present study.
Regarding asthma severity, the ISAAC protocol
defined severe asthmatics as those children who had
wheezing severe enough to limit speech in the last 12
months or had awoken in the night due to wheezing
in the last 12 months.
25,35 As defined using sleep
disturbance, speech difficulty, or both sleep disturbance
and speech difficulty, a significantly higher risk of severe
asthma was observed in AD with current rhinitis in 13, 9,
and 7 of 16 centers, respectively. Current rhinoconjunc-
tivitis was a significant risk factor for speech difficulty
a n df o rs l e e pd i s t u r b a n c ei n1 3o f1 6c e n t e r s .I n1 2o f1 6
centers, the risk was significantly higher for ADs who
had both conditions. The ISAAC protocol indicates that
the combination of nasal and ocular symptoms make this
question more specific for the diagnosis of AR and lessen
the chance of bias.
36
Because asthma is a heterogeneous disease with various
clinical presentations, we analyzed other indications of
severe asthma, such as having had more than 12 wheezing
episodes in the last 12 months. A significantly higher risk
of having more than 12 wheezing episodes in the last year
was associated with current rhinitis in nine of 16 centers
and was associated with current rhinoconjunctivitis in ten
of 16 centers. Other criteria included wheezing with
exercise and coughing during the night without having a
cold. Both were significantly associated with rhinitis and
rhinoconjunctivitis in all centers participating in this
study.
Although wheezing with exercise and nocturnal cough
without a cold are atypical asthma presentations, both were
significantly associated with current rhinitis and current
rhinoconjunctivitis.
In a program for asthma and AR control, Branda ˜o et al.
observed that a low education level, chronic rhinitis, and
more severe asthma were risk factors for hospitalizations
38
and emergency room visits due to increased asthma
severity.
37 Treatment for rhinitis was associated with a
reduction in asthma severity.
In conclusion, this epidemiologic study of Brazilian
adolescents revealed that both current rhinitis and current
rhinoconjunctivitis were associated with a high risk of
developing asthma and with more severe asthma. The
evaluation of both rhinitis and asthma is necessary for the
development of an adequate treatment plan.
APPENDIX
The Brazilian ISAAC’s Group comprises: Maria Socorro Cardoso
(Federal University of Amazon, Manaus); Almerinda R Silva (Federal
Table 3 - Odds ratio (OR) and 95% confidence interval (95% CI) for wheezing-related symptoms in Brazilian adolescents
from ISAAC Phase Three centers with current rhinoconjunctivitis.
Center
Wheezing last
year
OR (95%CI)
.12 wheezing
episodes last year
OR (95%CI)
Sleep disturb.
last year
OR (95%CI)
Speech problems
last year
OR (95%CI)
Asthma ever
OR (95%CI)
Wheezing from
exercise last year
OR (95%CI)
Nocturnal
coughing
last year
OR (95%CI)
Manaus 4.63 (3.68–5.83)* 2.57 (1.15–5.76)* 1.57 (1.09–2.27)* 3.06 (2.03–4.61)* 2.02 (1.60–2.57)* 3.38 (2.69–4.25)* 4.08 (3.22–5.17)*
Caruaru 3.21 (2.58–4.00)* 1.48 (0.63–3.50) 1.38 (0.96–1.98) 2.57 (1.66–3.99)* 2.44 (1.96–3.03)* 3.24 (2.60–4.04)* 3.20 (2.60–3.92)*
Aracaju 2.93 (2.37–3.61)* 2.15 (0.80–5.84) 1.61 (1.13–2.29)* 1.33 (0.89–2.01) 2.50 (2.00–3.12)* 3.24 (2.63–3.98)* 3.98 (3.25–4.86)*
Feira Santana 3.73 (2.85–4.87)* 2.19 (0.87–5.55) 1.52 (0.99–2.33) 1.35 (0.81–2.24) 2.18 (1.54–3.08)* 3.13 (2.42–4.04)* 3.96 (3.05–5.13)*
Salvador 3.40 (2.84–4.07) * 1.33 (0.64–2.77) 1.87 (1.39–2.52)* 1.65 (1.14–2.38)* 2.21 (1.80–2.75)* 2.93 (2.47–3.48)* 3.12 (2.63–3.71)*
Vito ´ria Conquista 3.18 (2.52–4.01) * 4.67 (1.48–14.69)* 2.88 (2.00–4.16)* 2.10 (1.38–3.22)* 2.83 (2.11–3.80)* 2.77 (2.20–3.48)* 2.92 (2.32–3.67)*
Brası ´lia 4.11 (3.32–5.08)* 4.56 (1.56–13.33)* 1.84 (1.30–2.60)* 2.75 (1.74–4.33)* 2.60 (2.05–3.29)* 3.30 (2.67–4.09)* 3.77 (3.05–4.65)*
Nova Iguac ¸u 6.04 (4.58–7.97)* 3.68 (1.16–11.6)* 5.41 (3.88–7.54)* 7.18 (4.71–10.90)* 4.20 (3.00–5.80)* 4.00 (3.00–5.25)* 5.45 (4.15–7.17)*
Sa ˜o Paulo West 3.62 (2.99–4.37)* 8.85 (3.59– 21.8)* 3.80 (3.07–4.68)* 5.47 (4.02–7.44)* 2.79 (2.15–3.60)* 3.27 (2.69–3.97)* 3.73 (3.11–4.47)*
Sa ˜o Paulo South 4.17 (3.32–5.23)* 1.49 (0.61–3.61)* 2.09 (1.45–3.01)* 2.31 (1.38–3.89)* 2.94 (2.23–3.87)* 3.23 (2.55–4.08)* 4.83 (3.85–6.05)*
Santo Andre ´ 3.70 (3.00–4.56)* 3.17 (1.40–7.20)* 2.04 (1.48–2.82)* 2.21 (1.42–3.42)* 2.88 (2.18–3.80)* 3.21 (2.57–4.00)* 3.93 (3.20–4.84)*
Curitiba 2.73 (2.25–3.31)* 2.32 (1.02–5.24)* 1.74 (1.25–2.42)* 1.72 (1.13–2.61)* 2.72 (2.13–3.48)* 2.95 (2.44–3.57)* 2.79 (2.34–3.33)*
Itajaı ´ 4.71 (3.62–6.12)* 2.37 (1.20–4.70)* 1.27 (0.81–2.01) 1.23 (0.65–2.32) 3.91 (2.97–5.14)* 4.38 (3.44–5.57)* 3.83 (3.05–4.82)*
Porto Alegre 4.18 (3.37–5.18)* 1.31 (0.82–2.10) 1.65 (1.16–2.34)* 1.61 (1.04–2.49)* 2.71 (2.19–3.35)* 3.80 (3.09–4.70)* 4.19 (3.42–5.15)*
Santa Maria 4.32 (3.33–5.60)* 1.96 (0.93–4.15) 1.43 (0.93–2.20)* 2.16 (1.30–3.62)* 3.18 (2.47–4.10)* 3.72 (2.94–4.72)* 3.93 (3.12–4.95)*
Santa Maria - rural 5.26 (4.14–6.68)* 3.34 (1.88–5.94)* 2.14 (1.45–3.17)* 3.03 (1.85–4.95)* 2.94 (2.20–3.97)* 3.19 (2.47–4.11)* 3.58 (2.80–4.60)*
*p,0.05.
Is allergic rhinitis a trivial disease?
Sole ´ D et al.
CLINICS 2011;66(9):1573-1577
1576University of Pernambuco, Caruaru); Jackeline Motta and Ricardo Gurgel
(Federal University of Sergipe, Aracaju); Leda Solano de Freitas (Federal
University of Bahia, Salvador); Wellington Borges (Hospital de Base do
Distrito Federal, Brası ´lia); Fa ´bio Kuschnir and Anto ˆnio Jose ´ Ledo Alves da
Cunha (Federal University of Rio de Janeiro, Nova Iguac ¸u); Anto ˆnio C
Pastorino and Cristina Miuki A Jacob (State University of Sa ˜o Paulo, Sa ˜o
Paulo); Karyn Chacon de Mello (Federal University of Sa ˜o Paulo, Sa ˜o
Paulo); Ca ´ssia Gonzalez and Neusa F Wandalsen (ABC Foundation School
of Medicine, Santo Andre ´); Carlos Riedi (Federal University of Parana ´,
Curitiba); Cla ´udia Benhardt (Federal University of Santa Catarina, Itajaı ´);
Gilberto B Fischer (Medical Federal Foundation of Rio Grande do Sul,
Porto Alegre); Vitor E. Cassol (Federal University of Rio Grande do Sul,
Santa Maria, Brazil).
REFERENCES
1. Bousquet J, Van Cauwenberge P, Khaltaev N, and the Aria Workshop
Group for the World Health Organization. Allergic rhinitis and its
impact on asthma. J Allergy Clin Immunol. 2001;108:S147–334, doi: 10.
1067/mai.2001.118891.
2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al.
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in
collaboration with the World Health Organization, GA(2)LEN and
AllerGen). Allergy. 2008;63 Suppl 86:8-160, doi: 10.1111/j.1398-9995.2007.
01620.x.
3. Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J,
et al. Common characteristics of upper and lower airways in rhinitis and
asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62
Suppl 84:1-41, doi: 10.1111/j.1398-9995.2007.01551.x.
4. Togias A. Rhinitis and asthma: evidence for respiratory system integra-
tion. J Allergy Clin Immunol. 2003;111:1171-83, doi: 10.1067/mai.2003.
1592.
5. Braunstahl GJ. United airways concept: what does it teach us about
systemic inflammation in airways disease? Proc Am Thorac Soc.
2009;6:652-4, doi: 10.1513/pats.200906-052DP.
6. Brown JL, Behndig AF, Sekerel BE, Pourazar J, Blomberg A, Kellyz FJ,
et al. Lower airways inflammation in allergic rhinitics: a comparison
with asthmatics and normal controls. Clin Exp Allergy.2007;37:688-95,
doi: 10.1111/j.1365-2222.2007.02695.x.
7. Bjo ¨rkste ´n B, Clayton T, Ellwood P, Stewart A, , Strachan D; ISAAC Phase
III Study Group. Worldwide time trends for symptoms of rhinitis and
conjunctivitis: Phase III of the International Study of Asthma and
Allergies in Childhood. Pediatr Allergy Immunol. 2008;19:110-24, doi: 10.
1111/j.1399-3038.2007.00601.x.
8. Aı ¨t-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J,
et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in
children: The International Study of Asthma and Allergies in Childhood
(ISAAC) Phase Three. Allergy. 2009;64:123-48, doi: 10.1111/j.1398-9995.
2008.01884.x.
9. Hansen JW, Thomsen SF, Nolte H, Backer V. Rhinitis: a complication to
asthma. Allergy. 2010;65:883-8, doi: 10.1111/j.1398-9995.2009.02290.x.
10. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence
for asthma and rhinitis comorbidity. J Allergy Clin Immunol.
2000;106:S201–5, doi: 10.1067/mai.2000.110151.
11. Peroni D, Piacentini G, Alfonsi L, Zerman L, Di Blasi P, Visona’ G, et al.
Rhinitis in pre-school children: prevalence, association with allergic
diseases and risk factors. Clin Exp Allergy. 2003;33:1349–54, doi: 10.
1046/j.1365-2222.2003.01766.x.
12. Hamouda S, Karila C, Connault T, Scheinmann P, de Blic J. Allergic
rhinitis in children with asthma: a questionnaire-based study. Clin Exp
Allergy. 2008;38:761-6, doi: 10.1111/j.1365-2222.2008.02953.x.
13. van den Nieuwenhof L, Schermer T, Bosch Y, Bousquet J, Heijdra Y,
Bor H, et al. Is physician-diagnosed allergic rhinitis a risk factor for
the development of asthma? Allergy. 2010;65:1049-55, doi: 10.1111/j.
1398-9995.2009.02316.x.
14. Pinto Pereira LM, Jackman J, Figaro N, Babootee N, Cudjoe G, Farrell S,
et al. Health burden of co-morbid asthma and allergic rhinitis in West
Indian children. Allergol Immunopathol (Madr). 2010;38:129-34, doi: 10.
1016/j.aller.2009.09.002.
15. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an
independent risk factor for adult-onset asthma. J Allergy Clin
Immunol. 2002;109:419–25, doi: 10.1067/mai.2002.121701.
16. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al.
Rhinitis and onset of asthma: a longitudinal population-based study.
Lancet. 2008;372:1049-57, doi: 10.1016/S0140-6736(08)61446-4.
17. Bisaccioni C, Aun MV, Cajuela E, Kalil J, Agondi RC, Giavina-Bianchi P.
Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis,
gastroesophageal reflux disease, vocal cord dysfunction andbronchiec-
tasis. Clinics. 2009;64:769-73, doi: 10.1590/S1807-59322009000800010.
18. Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of
illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr
retrospective study. Eur Respir J. 2003;21:116-22, doi: 10.1183/09031936.
03.00019502.
19. Halpern MT, Schmier JK, Richner R, Guo C, Togias A. Allergic rhinitis: a
potential cause of increased asthma medication use, costs, and
morbidity. J Asthma. 2004;41:117-26, doi: 10.1081/JAS-120026069.
20. Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency
and impact of allergic rhinitis in asthma patients in everyday general
medical practice: a French observational cross-sectional study. Allergy.
2008;63:292-8, doi: 10.1111/j.1398-9995.2007.01584.x.
21. Kang HY, Park CS, Bang HR, Sazonov V, Kim CJ. Effect of allergic
rhinitis on the use and cost of health services by children with asthma.
Yonsei Med J. 2008;49:521-9, doi: 10.3349/ymj.2008.49.4.521.
22. Taegtmeyer AB, Steurer-Stey C, Spertini F, Bircher A, Helbling A,
Miedinger D, et al. Allergic rhinitis in patients with asthma: the Swiss
LARA (Link Allergic Rhinitis in Asthma) survey. Curr Med Res Opin.
2009;25:1073-80, doi: 10.1185/03007990902820733.
23. Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency
and impact of allergic rhinitis in asthma patients in everyday general
medical practice: a French observational cross-sectional study. Allergy.
2008;63:292-8, doi: 10.1111/j.1398-9995.2007.01584.x.
24. PriceD, Zhang Q, Kocevar VS, YinDD, Thomas M. Effect of a concomitant
diagnosis of allergic rhinitis on asthma-related health care use by adults.
Clin Exp Allergy. 2005;35:282-7, doi: 10.1111/j.1365-2222.2005.02182.x.
25. Ponte EV, Franco R, Nascimento HF, Souza-Machado A, Cunha S,
Barreto ML, et al. Lack of control of severe asthma is associated with co-
existence of moderate-to-severe rhinitis. Allergy. 2008;63:564-9, doi: 10.
1111/j.1398-9995.2007.01624.x.
26. Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related
health care resource use among asthmatic children with and without
concomitant allergic rhinitis. Pediatrics. 2005;115:129-34.
27. Sole ´ D, Camelo-Nunes IC, Wandalsen GF, Melo KC, Naspitz CK. Is
rhinitis alone or associated with atopic eczema a risk factor for severe
asthma in children? Pediatr Allergy Immunol. 2005;16:121–5, doi: 10.
1111/j.1399-3038.2005.00227.x.
28. Sole ´ D, Camelo-Nunes IC, Wandalsen GF, Rosa ´rio Filho NA, Naspitz
CK; Brazilian ISAAC’s Group. Prevalence of rhinitis among Brazilian
schoolchildren: ISAAC phase 3 results. Rhinology. 2007;45:122-8.
29. Sole ´ D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC, Naspitz CK;
Brazilian ISAAC’s Group. Is the prevalence of asthma and related
symptoms among Brazilian children related to socioeconomic status?
J Asthma. 2008;45:19-25, doi: 10.1080/02770900701496056.
30. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewartt AW. ISAAC
Steering Committee - The international study of asthma and allergies in
childhood (ISAAC): phase three rationale and methods. Int J Tuberc
Lung Dis. 2005;9:10-16.
31. Williams H, Stewart A, von Mutius E, Cookson D, Anderson H R, The
International Study of Asthma and Allergies in Childhood (ISAAC) Phase
OneandThreeStudyGroups.Iseczema reallyontheincreaseworldwide?
J Allergy Clin Immunol. 2008;121:947-54, doi: 10.1016/j.jaci.2007.11.004.
32. Sole ´ D, Vanna AT, Yamada E, Rizzo MC, Naspitz CK. International
Study of Asthma and Allergies in Childhood (ISAAC) written
questionnaire: validation of the asthma component among Brazilian
children. J Invest Allergol Clin Immunol. 1998;8:376-82.
33. Vanna AT, Yamada E, Arruda LK, Naspitz CK, Sole D. International
Study of Asthma and Allergies in Childhood: validation of the rhinitis
symptom questionnaire and prevalence of rhinitis in schoolchildren in
Sa ˜o Paulo, Brazil. Pediatr Allergy Immunol. 2001;12:95-101, doi: 10.1034/
j.1399-3038.2001.012002095.x.
34. Yamada E, Vanna AT, Naspitz CK, Sole ´ D. International Study of Asthma
and Allergies in Childhood (ISAAC): validation of the written ques-
tionnaire (eczema component) and prevalence of atopic eczema among
Brazilian children. J Investig Allergol Clin Immunol. 2002;12: 34-41.
35. Asher MI, Montefort S, Bjo ¨rkste ´nB ,L a iC K ,S t r a c h a nD P ,W e i l a n d
SK, et al. Worldwide time trends in the prevalence of symp-
toms of asthma, allergic rhinoconjunctivitis, and eczema in
childhood: ISAAC Phases One and Three repeat multicountry
cross-sectional surveys. Lancet. 2006;368:733-43, doi: 10.1016/
S0140-6736(06)69283-0.
36. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al.
International Study of Asthma and Allergies in Childhood (ISAAC): rationale
and methods. Eur Respir J. 1995;8:483-91, doi: 10.1183/09031936.95.08030483.
37. Branda ˜o HV, Cruz CS, Pinheiro MC, Costa EA, Guimara ˜es A, Souza-
Machado A, et al. Risk factors for ER visits due to asthma exacerbations
in patients enrolled in a program for the control of asthma and allergic
rhinitis in Feira de Santana, Brazil. J Bras Pneumol. 2009;35:1168-73, doi:
10.1590/S1806-37132009001200002.
38. Branda ˜o HV, Cruz CMS, Santos IS Jr, Ponte EV, Guimara ˜es A, Cruz AA.
Hospitalizations for asthma: impact of a program for the control of
asthma and allergic rhinitis in Feira de Santana, Brazil. J Bras Pneumol.
2009;35:723-9, doi: 10.1590/S1806-37132009000800002.
CLINICS 2011;66(9):1573-1577 Is allergic rhinitis a trivial disease?
Sole ´ D et al.
1577